The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples